TYP 5.00% 2.1¢ tryptamine therapeutics limited

Ann: Exopharm LEAP Technology - Second Commercial Collaboration, page-9

  1. 16,819 Posts.
    lightbulb Created with Sketch. 356
    Exactly.

    The key point.

    If exosomes make delivery easier, faster and more reliable that's a total license to print money.

    The more collaborations , feasibility studies and trials they get involved in the closer they get.

    No one else is doing it.
 
watchlist Created with Sketch. Add TYP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.